<DOC>
	<DOCNO>NCT01509300</DOCNO>
	<brief_summary>RATIONALE : Conditioning total body irradiation ( TBI ) fludarabine , cyclophosphamide anti-thymocyte globulin may induce engraftment cross immunologic barrier set HLA-haploidentical allogeneic hematopoietic cell transplantation . In addition , T-cell depletion may contribute prevent develop severe acute graft versus host disease ( GVHD ) haploidentical transplantation . PURPOSE : This phase I/II trial evaluate safety efficacy TBI , fludarabine , cyclophosphamide antithymocyte globulin T-cell deplete graft haploidentical donor treat patient acute leukemia myelodysplastic syndrome .</brief_summary>
	<brief_title>HLA-haploidentical Hematopoietic Stem Cell Transplantation Children Adolescents With Acute Leukemia , Myelodysplastic Syndrome Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Vidarabine</mesh_term>
	<criteria>Inclusion Criteria 1 . Disease characteristic Acute lymphoblastic leukemia ( first remission , high risk ; beyond first remission ; refractory ) Acute myeloblastic leukemia ( first remission , high risk ; beyond first remission ; refractory ) Myelodysplastic syndrome Solid tumor ( Refractory/relapse ) 2 . No HLAidentical family member closely match ( 8 7 8 HLAlocus match ) unrelated marrow donor available 3 . HLAhaploidentical relate donor available Exclusion criterion 1 . Active fungal infection 2 . HIV positive 3 . Pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>TBI</keyword>
	<keyword>Fludarabine</keyword>
	<keyword>CD3 depletion</keyword>
	<keyword>Children adolescent</keyword>
	<keyword>Haploidentical hematopoietic stem cell transplantation</keyword>
</DOC>